These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8622661)

  • 1. Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.
    White DW; Pitoc GA; Gilmore TD
    Mol Cell Biol; 1996 Mar; 16(3):1169-78. PubMed ID: 8622661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins.
    White DW; Gilmore TD
    Oncogene; 1996 Sep; 13(5):891-9. PubMed ID: 8806678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
    Sif S; Gilmore TD
    J Virol; 1993 Dec; 67(12):7612-7. PubMed ID: 8230480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells.
    White DW; Roy A; Gilmore TD
    Oncogene; 1995 Mar; 10(5):857-68. PubMed ID: 7898928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins.
    Diehl JA; McKinsey TA; Hannink M
    Mol Cell Biol; 1993 Mar; 13(3):1769-78. PubMed ID: 8441412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A threshold nuclear level of the v-Rel oncoprotein is required for transformation of avian lymphocytes.
    Sachdev S; Diehl JA; McKinsey TA; Hans A; Hannink M
    Oncogene; 1997 May; 14(21):2585-94. PubMed ID: 9191058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
    Schatzle JD; Kralova J; Bose HR
    J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
    Morrison LE; Boehmelt G; Enrietto PJ
    Oncogene; 1992 Jun; 7(6):1137-47. PubMed ID: 1594245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEST-dependent cytoplasmic retention of v-Rel by I(kappa)B-alpha: evidence that I(kappa)B-alpha regulates cellular localization of c-Rel and v-Rel by distinct mechanisms.
    Rottjakob EM; Sachdev S; Leanna CA; McKinsey TA; Hannink M
    J Virol; 1996 May; 70(5):3176-88. PubMed ID: 8627798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.
    Hrdlicková R; Nehyba J; Bose HR
    J Virol; 1995 Jun; 69(6):3369-80. PubMed ID: 7745683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
    Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel.
    Sachdev S; Hannink M
    Mol Cell Biol; 1998 Sep; 18(9):5445-56. PubMed ID: 9710628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The v-Rel oncoprotein complexes with new Rel- and RelA-related proteins in transformed cells.
    Xu X; Gélinas C
    Virology; 1995 Mar; 207(2):362-8. PubMed ID: 7886940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
    Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
    J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.
    Diehl JA; Hannink M
    J Virol; 1993 Dec; 67(12):7161-71. PubMed ID: 8230438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutant v-rel with increased ability to transform B lymphocytes.
    Romero P; Humphries EH
    J Virol; 1995 Jan; 69(1):301-7. PubMed ID: 7983722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.
    Sarkar S; Gilmore TD
    Oncogene; 1993 Aug; 8(8):2245-52. PubMed ID: 8336947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discreet mutations from c-Rel to v-Rel alter kappaB DNA recognition, IkappaBalpha binding, and dimerization: implications for v-Rel oncogenicity.
    Phelps CB; Ghosh G
    Oncogene; 2004 Feb; 23(6):1229-38. PubMed ID: 14961076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.
    Mosialos G; Hamer P; Capobianco AJ; Laursen RA; Gilmore TD
    Mol Cell Biol; 1991 Dec; 11(12):5867-77. PubMed ID: 1944267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.